









市場行情
/
股票
/
nasdaq-kmts
/

Kestra Medical Technologies Ltd

KMTS

27.520USD

-0.030-0.11%

收盤 12/24, 13:00（美東）報價延遲15分鐘

1.42B總市值

虧損本益比TTM



Kestra Medical Technologies Ltd

27.520

-0.030-0.11%

概覽公司財務分析

概覽

公司

財務

分析

關於 Kestra Medical Technologies Ltd 公司

Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.

Kestra Medical Technologies Ltd簡介



公司代碼KMTS

公司名稱Kestra Medical Technologies Ltd

上市日期Mar 06, 2025

CEOWebster (Brian Daniel)

員工數量330

證券類型Ordinary Share

年結日Mar 06

公司地址3933 Lake Washington Blvd Ne

城市KIRKLAND

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編98033

電話14252798002

網址

公司代碼KMTS

上市日期Mar 06, 2025

CEOWebster (Brian Daniel)

Kestra Medical Technologies Ltd公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Brian Webster

President, Chief Executive Officer, Founder, Director

309.34K

-22.19%

Ms. Traci S. Umberger

Chief Administrative Officer, General Counsel, Director

104.92K

-13.17%

Dr. Elizabeth Kwo, M.D.

Independent Director

21.82K

Mr. Vaseem Mahboob

Chief Financial Officer

14.84K

-59.79%

Mr. Conor Hanley

Independent Director

13.12K

Mr. Phillip D. Foshee, Jr.

Senior Vice President - Research & Development

Ms. Mary Katherine (Kay) Ladone

Independent Director

Mr. Maxwell Bikoff

Independent Director

Mr. Al Ford

Chief Commercial Officer

Ms. Debra Schotz

Senior Vice President - Marketing

名稱

名稱/職務

職務

持股

持股變動

Mr. Brian Webster

President, Chief Executive Officer, Founder, Director

309.34K

-22.19%

Ms. Traci S. Umberger

Chief Administrative Officer, General Counsel, Director

104.92K

-13.17%

Dr. Elizabeth Kwo, M.D.

Independent Director

21.82K

Mr. Vaseem Mahboob

Chief Financial Officer

14.84K

-59.79%

Mr. Conor Hanley

Independent Director

13.12K

Mr. Phillip D. Foshee, Jr.

Senior Vice President - Research & Development

收入明細

由於公司未披露，未能獲取相關數據

由於公司未披露，未能獲取相關數據

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 11月17日週一

持股股東

股東類型

持股股東

佔比

Bain Capital Private Equity, LP

46.31%

Fidelity Management & Research Company LLC

7.45%

Endeavour Medtech Growth II LP

4.54%

Ally Bridge Group (HK) Limited

3.91%

T. Rowe Price Associates, Inc.

3.11%

其他

34.68%

持股股東

佔比

Bain Capital Private Equity, LP

46.31%

Fidelity Management & Research Company LLC

7.45%

Endeavour Medtech Growth II LP

4.54%

Ally Bridge Group (HK) Limited

3.91%

T. Rowe Price Associates, Inc.

3.11%

其他

34.68%

股東類型

持股股東

佔比

Private Equity

46.31%

Investment Advisor

21.46%

Investment Advisor/Hedge Fund

11.85%

Corporation

4.54%

Venture Capital

2.82%

Hedge Fund

1.97%

Individual Investor

0.99%

Research Firm

0.20%

Bank and Trust

0.03%

其他

9.84%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

138

48.47M

94.21%

+1.86M

2025Q2

49.39M

96.22%

+48.70M

2025Q1

47.97M

93.41%

+47.97M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Bain Capital Private Equity, LP

27.02M

52.52%

Jun 30, 2025

Fidelity Management & Research Company LLC

2.84M

5.52%

+531.65K

+23.05%

Jun 30, 2025

Endeavour Medtech Growth II LP

2.65M

5.14%

+2.65M

Mar 31, 2025

Ally Bridge Group (HK) Limited

2.28M

4.44%

Jun 30, 2025

T. Rowe Price Associates, Inc.

990.60K

1.93%

+141.18K

+16.62%

Jun 30, 2025

Omega Fund Management, LLC

1.65M

3.2%

-150.00K

-8.35%

Jun 30, 2025

AllianceBernstein L.P.

1.31M

2.55%

+128.31K

+10.84%

Jun 30, 2025

Brown Advisory

580.02K

1.13%

+29.61K

+5.38%

Jun 30, 2025

Eventide Asset Management, LLC

1.06M

2.06%

+785.56K

+285.66%

Jun 30, 2025

Fidelity Institutional Asset Management

857.25K

1.67%

-35.40K

-3.97%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

Global X HealthTech ETF

0.43%

Goldman Sachs Innovate Equity ETF

0.13%

Fidelity Blue Chip Growth ETF

0.06%

JPMorgan BetaBuilders US Small Cap Equity ETF

0.04%

iShares Russell 2000 Growth ETF

0.02%

Fidelity Nasdaq Composite Index ETF

0.01%

Global X Russell 2000 ETF

0.01%

Schwab U.S. Small-Cap ETF

0.01%

iShares Russell 2000 ETF

0.01%

iShares Morningstar Small-Cap ETF

0.01%

Global X HealthTech ETF

佔比0.43%

Goldman Sachs Innovate Equity ETF

佔比0.13%

Fidelity Blue Chip Growth ETF

佔比0.06%

JPMorgan BetaBuilders US Small Cap Equity ETF

佔比0.04%

iShares Russell 2000 Growth ETF

佔比0.02%

Fidelity Nasdaq Composite Index ETF

佔比0.01%

Global X Russell 2000 ETF

佔比0.01%

Schwab U.S. Small-Cap ETF

佔比0.01%

iShares Russell 2000 ETF

佔比0.01%

iShares Morningstar Small-Cap ETF

佔比0.01%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Kestra Medical Technologies Ltd的前五大股東是誰？



Kestra Medical Technologies Ltd的前五大股東如下：
Bain Capital Private Equity, LP
持有股份：27.02M
佔總股份比例：52.52%。
Fidelity Management & Research Company LLC
持有股份：2.84M
佔總股份比例：5.52%。
Endeavour Medtech Growth II LP
持有股份：2.65M
佔總股份比例：5.14%。
Ally Bridge Group (HK) Limited
持有股份：2.28M
佔總股份比例：4.44%。
T. Rowe Price Associates, Inc.
持有股份：990.60K
佔總股份比例：1.93%。

Kestra Medical Technologies Ltd的前三大股東類型是什麼？



Kestra Medical Technologies Ltd 的前三大股東類型分別是：
Bain Capital Private Equity, LP
Fidelity Management & Research Company LLC
Endeavour Medtech Growth II LP